Oncogene - Table of Contents alert Volume 35 Issue 24

If you are unable to see the message below, click here to view.

Advertisement Oncogenesis Focus Collection: Cancer & Metabolism While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells. Explore the complete Special Issue in full. TABLE OF CONTENTS Volume 35, Issue 24 (June 2016) In this issue Review Original Articles Short Communication Oncogenomics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement FCS 2016 is jointly organised by the 6 major institutes in Singapore and features an impressive line-up of speakers including Nobel Laureate Tomas Lindahl. It converges the latest cancer discoveries around the world, the meeting promises ground breaking and innovative insights into cancer research. So register now to secure your chance to interact and learn from the experts!   Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage Review Top CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation A-S Tigan, F Bellutti, K Kollmann, G Tebb and V Sexl Oncogene 2016 35: 3083-3091; advance online publication, October 26, 2015; 10.1038/onc.2015.407 Abstract | Full Text Original Articles Top Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells D J Gordon, M Motwani and D Pellman Oncogene 2016 35: 3092-3102; advance online publication, October 12, 2015; 10.1038/onc.2015.368 Abstract | Full Text Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer D C Borcherding, W Tong, E R Hugo, D F Barnard, S Fox, K LaSance, E Shaughnessy and N Ben-Jonathan Oncogene 2016 35: 3103-3113; advance online publication, October 19, 2015; 10.1038/onc.2015.369 Abstract | Full Text The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth E Palazzo, M Kellett, C Cataisson, A Gormley, P W Bible, V Pietroni, N Radoja, J Hwang, M Blumenberg, S H Yuspa and M I Morasso Oncogene 2016 35: 3114-3124; advance online publication, November 2, 2015; 10.1038/onc.2015.380 Abstract | Full Text A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization A M Nowicka, I Häuselmann, L Borsig, S Bolduan, M Schindler, P Schraml, M Heikenwalder and H Moch Oncogene 2016 35: 3125-3138; advance online publication, October 26, 2015; 10.1038/onc.2015.400 Abstract | Full Text Nestin regulates proliferation and invasion of gastrointestinal stromal tumor cells by altering mitochondrial dynamics J Wang, J Cai, Y Huang, Q Ke, B Wu, S Wang, X Han, T Wang, Y Wang, W Li, C Lao, W Song and A P Xiang Oncogene 2016 35: 3139-3150; advance online publication, October 5, 2015; 10.1038/onc.2015.370 Abstract | Full Text Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition OPEN Q Zhang, T Wei, K Shim, K Wright, K Xu, H L Palka-Hamblin, A Jurkevich and S Khare Oncogene 2016 35: 3151-3162; advance online publication, October 5, 2015; 10.1038/onc.2015.365 Abstract | Full Text Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness M Schulze, O Fedorchenko, T G Zink, C B Knobbe-Thomsen, S Kraus, S Schwinn, A Beilhack, G Reifenberger, C M Monoranu, A-L Sirén, E Jeanclos and A Gohla Oncogene 2016 35: 3163-3177; advance online publication, November 9, 2015; 10.1038/onc.2015.376 Abstract | Full Text Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation J Berscheminski, J Brun, T Speiseder, P Wimmer, W H Ip, M Terzic, T Dobner and S Schreiner Oncogene 2016 35: 3178-3189; advance online publication, October 19, 2015; 10.1038/onc.2015.378 Abstract | Full Text The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer C Rey, B Faustin, I Mahouche, R Ruggieri, C Brulard, F Ichas, I Soubeyran, L Lartigue and F De Giorgi Oncogene 2016 35: 3190-3200; advance online publication, November 2, 2015; 10.1038/onc.2015.379 Abstract | Full Text Short Communication Top ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer OPEN M van Geldermalsen, Q Wang, R Nagarajah, A D Marshall, A Thoeng, D Gao, W Ritchie, Y Feng, C G Bailey, N Deng, K Harvey, J M Beith, C I Selinger, S A O'Toole, J E J Rasko and J Holst Oncogene 2016 35: 3201-3208; advance online publication, October 12, 2015; 10.1038/onc.2015.381 Abstract | Full Text Oncogenomics Top Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma M B Schabath, E A Welsh, W J Fulp, L Chen, J K Teer, Z J Thompson, B E Engel, M Xie, A E Berglund, B C Creelan, S J Antonia, J E Gray, S A Eschrich, D-T Chen, W D Cress, E B Haura and A A Beg Oncogene 2016 35: 3209-3216; advance online publication, October 19, 2015; 10.1038/onc.2015.375 Abstract | Full Text Advertisement Have you checked out the Oncogene top 10? We have a continuously updated list of articles that highlight what has been downloaded by our website users over the past 7 days. Take a look as you may have missed out on something that could help with your research! Click here to view the top 10 Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.